Multicenter evaluation of the antimicrobial activity for six broad-spectrum β-lactams in Venezuela using the Etest method

Diagnostic Microbiology and Infectious Disease

Volumn 30, Issue 1, 1998, Pages 45-52

  Pfaller, Michael A ^a   Jones, Ronald N ^a   Doern, Gary V ^a  

^a UNIVERSITY OF IOWA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CEFEPIME; CEFOTAXIME; CEFTAZIDIME; IMIPENEM; OXACILLIN; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM;

ACINETOBACTER; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; E TEST; ENTEROBACTER; EVALUATION AND FOLLOW UP; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; KLEBSIELLA; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL; STAPHYLOCOCCUS; VENEZUELA;

ACINETOBACTER; ANTI-BACTERIAL AGENTS; BETA-LACTAMASES; BETA-LACTAMS; DRUG RESISTANCE, MICROBIAL; DRUG RESISTANCE, MULTIPLE; ENTEROBACTERIACEAE; GRAM-NEGATIVE AEROBIC RODS AND COCCI; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; STAPHYLOCOCCUS AUREUS; VENEZUELA;

EID: 0031940712     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0732-8893(97)00158-2     Document Type: Article

References (34)

1. Barradell LB, Bryson HM. Cefepime A review of its antibacterial activity, pharmacokinetic properties and therapeutic use . Drugs. 47:1994;471-505.
2. Berne TV, Yellin AE, Appelbaum MD. A clinical comparison of cefepime and metronidazole versus gentamicin and clindamycin in the antibiotic management of surgically treated advanced appendicitis. Surg Gynecol Obstet. 177:(suppl):1993;18-22.
3. Brown DFJ, Brown L. Evaluation of the Etest A novel method of quantifying antimicrobial activity . J Antimicrob Chemother. 27:1991;185-190.
4. Jones RN, Salazar JC, Pfaller MA, Doern GV, Lozano F. Multicenter evaluation of the antimicrobial activity for six broad-spectrum β-lactams in Colombia using the Etest method. Diagn Microbiol Infect Dis. 29:1997;265-272.
5. Frei R, Jones RN, Pignatari AC, Yamane N, Marco F, Hoban DJ. Antimicrobial activity of FK-037, a new broad-spectrum cephalosporin. International in vitro comparison with cefepime and ceftazidime. Diagn Microbiol Infect Dis. 18:1994;167-173.
6. Fung-Tomc JC, Gradelski E, Huczko E, Doughterty TJ, Kessler RE, Bonner DP. Differences in the resistant variants of Enterobacter cloacae selected by extended-spectrum cephalosporins. Antimicrob Agents Chemother. 40:1996;1289-1293.
7. Hancock REW, Bellido F. Factors involved in the enhanced efficacy against gram-negative bacteria of fourth generation cephalosporins. J Antimicrob Chemother. 29:(suppl A):1992;1-6.
8. Hoepelman AIM, Kieft H, Aoun M. International comparative study of cefepime and ceftazidime in the treatment of community-acquired lower respiratory tract infections. J Antimicrob Chemother. 32:(suppl B):1993;175-186.
9. Jacoby GA, Carreras I. Activities of β-lactam antibiotics against Escherichia coli strains producing extended-spectrum β-lactamases. Antimicrob Agents Chemother. 34:1990;858-862.
10. Jones RN, Kehrberg EN, Erwin ME, Anderson SC. The prevalence of important pathogens and the antimicrobial activity of parenteral drugs at numerous medical centers in the United States Study on the Threat of emerging resistance, real or perceived? Diagn Microbiol Infect Dis. 19:1994;203-215.
11. Jones RN, Marshall SA. Antimicrobial activity of cefepime tested against Bush group 1 β-lactamase-producing strains resistant to ceftazidime. Diagn Microbiol Infect Dis. 19:1994;33-38.
12. Jones RN, Pfaller MA, Doern GV, Erwin ME, Hollis RJ, the Cefepime Study Group (1998) Antimicrobial activity and spectrum investigation of eight broad-spectrum β-lactam drugs: a 1997 surveillance trial in 102 medical centers in the United States. Clin Infect Dis (in press).
13. McCabe R, Chirurgi V, Farkos SA, Haddow A, Heinz G, Greene S. A new therapeutic option for the treatment of pneumonia. Am J Med. 100:(suppl 6A):1996;60S-67S.
14. Moosdeen F. The evolution of resistance to cephalosporins. Clin Infect Dis. 24:1997;487-493.
15. Performance Standards for Antimicrobial Disk Susceptibility Tests. Approved Standard M2-A6. 1997;National Committee for Clinical Laboratory Standards, Wayne, PA.
16. Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria That Grow Aerobically. Approved Standard M7-A4. 1997;National Committee for Clinical Laboratory Standards, Wayne, PA.
17. Neu HC. Safety of cefepime A new extended-spectrum parenteral cephalosporin . Am J Med. 100:(suppl 6A):1996;68S-75S.
18. Newton ER, Yeomans ER, Pastorek JG. Randomized comparative study of cefepime and cefotaxime in the treatment of acute obstetric and gynecological infections. J Antimicrob Chemother. 32:(suppl B):1993;195-204.
19. Phelps DJ, Carlton DD, Farrell CA, Kessler RE. Affinity of cephalosporins for β-lactamases as a factor in antibacterial efficacy. Antimicrob Agents Chemother. 29:1986;845-848.
20. Philippon A, Arlet G, Lagrange PH. Origin and impact of plasmid-mediated extended-spectrum beta-lactamases. Eur J Clin Microbiol Infect Dis. 13:1994;17-29.
21. Pfaller MA, Jones RN, Marshall SA, Coffman SL, Hollis RJ, Edmond MB, Wenzel RP. Inducible Amp C β-lactamase producing gram-negative bacilli from blood stream infections Frequency, antimicrobial susceptibility, and molecular epidemiology in a National Surveillance Program (SCOPE) . Diagn Microbiol Infect Dis. 28:1997;211-219.
22. Ramphal R, Gucalp R, Rotstein C, Cimino M, Oblon D. Clinical experience with single agent and combination regimens in the management of infection in the febrile neutropenic patient. Am J Med. 100:(suppl 6A):1996;83S-89S.
23. Sader HS, Mimica I, Rossi F, Zoccoli C, Montelli AC, Sampaio JLM, Segura AJA, Magalhaes M, Nowakonski A, Mendes CMF. Evaluation of the in vitro activity of cefepime compared to other broad-spectrum cephalosporins against clinical isolates from eighteen Brazilian hospitals by using the Etest. Diagn Microbiol Infect Dis. 28:1997;87-92.
24. Saez-Llorens X, Castano E, Garcia E, Baez C, Perez M, Tejeira F, McCracken GH Jr. Prospective randomized comparison of cefepime and cefotaxime for treatment of bacterial meningitis in infants and children. Antimicrob Agents Chemother. 39:1995;937-940.
25. Sanders WE, Tenney JH, Kessler RE. Efficacy of cefepime in the treatment of infections due to multiply resistant Enterobacter species. Clin Infect Dis. 23:1996;454-461.
26. Sanders CC. Cefepime The next generation? Clin Infect Dis. 17:1993;369-379.
27. Sanders WE, Sanders CC. Inducible β-lactamases Clinical and epidemiological implications for the use of newer cephalosporins . Rev Infect Dis. 10:1988;830-838.
28. Schrank JH Jr, Kelley JW, McAllister CK. Randomized comparison of cefepime and ceftazidime for treatment of hospitalized patients with gram-negative bacteremia. Clin Infect Dis. 20:1995;56-58.
29. Schwartz R, Das Young LR, Ramirez-Ronda C, Frank E. Current and future management of serious skin and skin-structure infections. Am J Med. 100:(suppl 6A):1996;90S-95S.
30. Spangler SK, Jacobs MR, Appelbaum PC. Susceptibilities of 177 penicillin-susceptible and -resistant pneumonococci to FK 037, cefpirome, cefepime, ceftriaxone, cefotaxime, ceftazidime, imipenem, biapenem, meropenem, and vancomycin. Antimicrob Agents Chemother. 38:1994;898-900.
31. Spencer RC, Bauernfeind A, Garcia-Rodriguez J, Jarlier V, Pfaller M, Turnidge J, Voss A. Surveillance of the current resistance of nosocomial pathogens to antibacterials. Clin Microbiol Infect. 3:(suppl 1):1997;S21-S35.
32. Swartz MN. Hospital-acquired infections Diseases with increasingly limited therapies . Proc Natl Acad Sci USA. 91:1994;2420-2427.
33. Thauvin-Eliopoulos C, Tripodi MF, Moellering RC Jr, Eliopoulos GM. Efficacies of piperacillin-tazobactam and cefepime in rats with experimental intra-abdominal abscesses due to an extended-spectrum β-lactamase-producing strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 41:1997;1053-1057.
34. Thornsberry C, Yee YC. Comparative activity of eight antibiotics against clinical bacterial isolates from the United States Broth microdilution (MicroScan) and the Etest method . Am J Med. 100:(suppl 6A):1996;26S-38S.